BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 29776716)

  • 1. Two-Step Senescence-Focused Cancer Therapies.
    Sieben CJ; Sturmlechner I; van de Sluis B; van Deursen JM
    Trends Cell Biol; 2018 Sep; 28(9):723-737. PubMed ID: 29776716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature aging/senescence in cancer cells facing therapy: good or bad?
    Gonzalez LC; Ghadaouia S; Martinez A; Rodier F
    Biogerontology; 2016 Feb; 17(1):71-87. PubMed ID: 26330289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To clear, or not to clear (senescent cells)? That is the question.
    Lujambio A
    Bioessays; 2016 Jul; 38 Suppl 1():S56-64. PubMed ID: 27417123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
    Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting normal and cancer senescent cells as a strategy of senotherapy.
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SASP: Tumor Suppressor or Promoter? Yes!
    Rao SG; Jackson JG
    Trends Cancer; 2016 Nov; 2(11):676-687. PubMed ID: 28741506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The senescence journey in cancer immunoediting.
    Zingoni A; Antonangeli F; Sozzani S; Santoni A; Cippitelli M; Soriani A
    Mol Cancer; 2024 Apr; 23(1):68. PubMed ID: 38561826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic senescence: a multi-functional perspective.
    Baker DJ; Alimirah F; van Deursen JM; Campisi J; Hildesheim J
    Oncotarget; 2017 Apr; 8(16):27661-27672. PubMed ID: 28416761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
    Malaquin N; Martinez A; Rodier F
    Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy.
    Jiang B; Zhang W; Zhang X; Sun Y
    Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.
    Di Mitri D; Alimonti A
    Trends Cell Biol; 2016 Mar; 26(3):215-226. PubMed ID: 26564316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Senescence: The Sought or the Unwanted?
    Sun Y; Coppé JP; Lam EW
    Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular senescence in cancer: clinical detection and prognostic implications.
    Domen A; Deben C; Verswyvel J; Flieswasser T; Prenen H; Peeters M; Lardon F; Wouters A
    J Exp Clin Cancer Res; 2022 Dec; 41(1):360. PubMed ID: 36575462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
    Lau L; David G
    Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
    [No Abstract]   [Full Text] [Related]  

  • 19. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
    Niklander SE; Lambert DW; Hunter KD
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular senescence and tumor promotion: Is aging the key?
    Loaiza N; Demaria M
    Biochim Biophys Acta; 2016 Apr; 1865(2):155-67. PubMed ID: 26845683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.